92. ADHD: Pills, Profits, and Pushback w/ Gretchen LeFever Watson PhD
Description
I am re-releasing one of my favorite earlier conversations with Gretchen LeFever Watson, Ph.D., a clinical psychologist whose research and intervention projects have received international scholarly and media attention, including appearances on TV and radio programs. Dr. Watson was among the first to document drug overtreatment for ADHD in the U.S. and to demonstrate that disruptive conduct can be successfully reduced through school wide behavioral interventions. In her paper, she chronicles the personal and professional attacks she experienced as a result of challenging industry interests. This serves as a testament to the potential hindrance of pioneering research and the adverse effects it can have.
MUST READ: Shooting the Messenger: The Case of ADHD | SpringerLink
If you are in a crisis or think you have an emergency, call your doctor or 911. If you're considering suicide, call 1-800-273-TALK to speak with a skilled trained counselor.
RADICALLY GENUINE PODCAST
Dr. Roger McFillin / Radically Genuine Website
Twitter: Roger K. McFillin, Psy.D., ABPP
Substack | Radically Genuine | Dr. Roger McFillin
—----------
ADDITIONAL RESOURCES
12:00 - Table 7, DSM-IV to DSM-5 Attention-Deficit/Hyperactivity Disorder Comparison - DSM-5 Changes - NCBI Bookshelf
24:00 - ADHD Experts Conflicts of Interest
25:00 - Russell A. Barkley, Ph.D. - Google Scholar
29:00 - Harvard Physicians Sanctioned for Failing to File Proper Disclosure – Policy & Medicine
52:00 - How to Rewire Your Brain: 6 Neuroplasticity Exercises
1:08:00 - Over 25% of People Click the First Google Search Result
1:13:00 - Change.org Petition: Protect Children: Stop Overuse of Psychoactive Drugs
RADICALLY GENUINE PODCAST
Dr. Roger McFillin / Radically Genuine Website
Dr. Roger McFillin (@DrMcFillin) / X
Substack | Radically Genuine | Dr. Roger McFillin
Conscious Clinician Collective
PLEASE SUPPORT OUR PARTNERS
15% Off Pure Spectrum CBD (Code: RadicallyGenuine)
10% off Lovetuner click here
—-----------